Form 4: Quest Diagnostics Executive Kuppusamy Karthik Reports Stock Transactions
SEC Form 4 Filing
SVP of Clinical Solutions at Quest Diagnostics, Kuppusamy Karthik, reports acquisition of restricted stock units and stock options, along with adjustments to existing holdings.
Summary
- Karthik Kuppusamy, SVP of Clinical Solutions at Quest Diagnostics, filed a Form 4 detailing changes in beneficial ownership.
- On February 12, 2025, Kuppusamy acquired 2,269 shares of common stock through a restricted stock unit award.
- Kuppusamy also acquired 8,702 non-qualified stock options with an exercise price of $165.3, vesting in three equal annual installments starting February 12, 2026, and expiring on February 12, 2035.
- The report indicates direct ownership of 12,066 shares of common stock following the reported transactions.
- Additionally, Kuppusamy indirectly owns 1,588 shares through the company's stock purchase plan and 358 shares through the 401(k) plan.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing reflecting stock transactions. The acquisition of stock and options could be seen as a slightly positive signal, but it's not a strong indicator.
Positives
- The acquisition of restricted stock units and stock options suggests confidence in the company's future performance from the executive's perspective.
- Increased equity ownership aligns the executive's interests with those of the shareholders.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedule of the stock options implies a multi-year commitment from the executive.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions. They are closely watched by investors to gauge executive sentiment and potential future actions.
Stakeholder Impact
- The transactions may have a minor positive impact on shareholder sentiment due to the executive's increased stake in the company.
- Employees participating in the stock purchase plan and 401(k) plan are indirectly affected by the changes in stock ownership.
Key Dates
| Date | Description |
|---|---|
| 02/12/2025 | Date of transaction: Acquisition of restricted stock units and stock options. |
| 02/12/2026 | First vesting date for the non-qualified stock options. |
| 02/12/2035 | Expiration date for the non-qualified stock options. |
| 02/14/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Quest Diagnostics, Stock Options, Restricted Stock Units, Beneficial Ownership, Kuppusamy Karthik, DGX
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.